Evrofarma SA (EVROF) — Cash Flow Quality Index
Evrofarma SA (EVROF) has a Cash Flow Quality Index of -0.35x as of June 2023. Operating cash flow of €-248.50K is below net income of €708.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore EVROF long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Evrofarma SA Cash Flow Quality Index (2015–2022)
Historical Cash Flow Quality Index for Evrofarma SA across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Evrofarma SA to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Evrofarma SA (2015–2022)
Year-by-year earnings quality comparison for Evrofarma SA. For live market cap and the full company financial profile, see Evrofarma SA market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.72x | €2.44 Million | €1.42 Million | ▲ +27.4% |
| 2020 | 1.35x | €1.46 Million | €1.08 Million | ▼ -88.1% |
| 2019 | 11.32x | €1.78 Million | €157.00K | ▲ +383.7% |
| 2018 | 2.34x | €2.29 Million | €979.00K | ▼ -59.6% |
| 2017 | 5.79x | €3.11 Million | €536.00K | ▲ +386.2% |
| 2016 | 1.19x | €1.08 Million | €907.00K | ▼ -54.8% |
| 2015 | 2.64x | €1.39 Million | €527.00K | — |